TY - JOUR
T1 - Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni
AU - Changkwanyeun, Ruchirada
AU - Yamaguchi, Tomoyuki
AU - Kongsoi, Siriporn
AU - Changkaew, Kanjana
AU - Yokoyama, Kazumasa
AU - Kim, Hyun
AU - Suthienkul, Orasa
AU - Usui, Masaru
AU - Tamura, Yutaka
AU - Nakajima, Chie
AU - Suzuki, Yasuhiko
N1 - Publisher Copyright:
Copyright © 2016 John Wiley & Sons, Ltd.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Amino acid substitutions providing quinolone resistance to Campyloabcter jejuni have been found in the quinolone resistance-determining region of protein DNA gyrase subunit A (GyrA), with the highest frequency at position 86 followed by position 90. In this study, wild-type and mutant recombinant DNA gyrase subunits were expressed in Escherichia coli and purified using Ni-NTA agarose column chromatography. Soluble 97 kDa GyrA and 87 kDa DNA gyrase subunit B were shown to reconstitute ATP-dependent DNA supercoiling activity. A quinolone-inhibited supercoiling assay demonstrated the roles of Thr86Ile, Thr86Ala, Thr86Lys, Asp90Asn, and Asp90Tyr amino acid substitutions in reducing sensitivity to quinolones. The marked effect of Thr86Ile on all examined quinolones suggested the advantage of this substitution in concordance with recurring isolation of quinolone-resistant C. jejuni. An analysis of the structure-activity relationship showed the importance of the substituent at position 8 in quinolones to overcome the effect of Thr86Ile. Sitafloxacin (SIT), which has a fluorinate cyclopropyl ring at R-1 and a chloride substituent at R-8, a characteristic not found in other quinolones, showed the highest inhibitory activity against all mutant C. jejuni gyrases including ciprofloxacin-resistant mutants. The results suggest SIT as a promising drug for the treatment of campylobacteriosis caused by CIP-resistant C. jejuni.
AB - Amino acid substitutions providing quinolone resistance to Campyloabcter jejuni have been found in the quinolone resistance-determining region of protein DNA gyrase subunit A (GyrA), with the highest frequency at position 86 followed by position 90. In this study, wild-type and mutant recombinant DNA gyrase subunits were expressed in Escherichia coli and purified using Ni-NTA agarose column chromatography. Soluble 97 kDa GyrA and 87 kDa DNA gyrase subunit B were shown to reconstitute ATP-dependent DNA supercoiling activity. A quinolone-inhibited supercoiling assay demonstrated the roles of Thr86Ile, Thr86Ala, Thr86Lys, Asp90Asn, and Asp90Tyr amino acid substitutions in reducing sensitivity to quinolones. The marked effect of Thr86Ile on all examined quinolones suggested the advantage of this substitution in concordance with recurring isolation of quinolone-resistant C. jejuni. An analysis of the structure-activity relationship showed the importance of the substituent at position 8 in quinolones to overcome the effect of Thr86Ile. Sitafloxacin (SIT), which has a fluorinate cyclopropyl ring at R-1 and a chloride substituent at R-8, a characteristic not found in other quinolones, showed the highest inhibitory activity against all mutant C. jejuni gyrases including ciprofloxacin-resistant mutants. The results suggest SIT as a promising drug for the treatment of campylobacteriosis caused by CIP-resistant C. jejuni.
KW - Campylobacter jejuni
KW - DNA gyrase
KW - mutation
KW - quinolone resistance
UR - http://www.scopus.com/inward/record.url?scp=84958781206&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958781206&partnerID=8YFLogxK
U2 - 10.1002/dta.1937
DO - 10.1002/dta.1937
M3 - Article
C2 - 26857529
AN - SCOPUS:84958781206
SN - 1942-7603
VL - 8
SP - 1071
EP - 1076
JO - Drug Testing and Analysis
JF - Drug Testing and Analysis
IS - 10
ER -